Literature DB >> 26470820

Universal vs Risk Factor Screening for Methicillin-Resistant Staphylococcus aureus in a Large Multicenter Tertiary Care Facility in Canada.

V R Roth1, T Longpre2, M Taljaard3, D Coyle3, K N Suh1, K A Muldoon4, K Ramotar3, A Forster1.   

Abstract

OBJECTIVE To assess the clinical effectiveness of a universal screening program compared with a risk factor-based program in reducing the rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) among admitted patients at the Ottawa Hospital. DESIGN Quasi-experimental study. SETTING Ottawa Hospital, a multicenter tertiary care facility with 3 main campuses, approximately 47,000 admissions per year, and 1,200 beds. METHODS From January 1, 2006 through December 31, 2007 (24 months), admitted patients underwent risk factor-based MRSA screening. From January 1, 2008 through August 31, 2009 (20 months), all patients admitted underwent universal MRSA screening. To measure the effectiveness of this intervention, segmented regression modeling was used to examine monthly nosocomial MRSA incidence rates per 100,000 patient-days before and during the intervention period. To assess secular trends, nosocomial Clostridium difficile infection, mupirocin prescriptions, and regional MRSA rates were investigated as controls. RESULTS The nosocomial MRSA incidence rate was 46.79 cases per 100,000 patient-days, with no significant differences before and after intervention. The MRSA detection rate per 1,000 admissions increased from 9.8 during risk factor-based screening to 26.2 during universal screening. A total of 644 new nosocomial MRSA cases were observed in 1,448,488 patient-days, 323 during risk factor-based screening and 321 during universal screening. Secular trends in C. difficile infection rates and mupirocin prescriptions remained stable after the intervention whereas population-level MRSA rates decreased. CONCLUSION At Ottawa Hospital, the introduction of universal MRSA admission screening did not significantly affect the rates of nosocomial MRSA compared with risk factor-based screening. Infect. Control Hosp. Epidemiol. 2015;37(1):41-48.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26470820     DOI: 10.1017/ice.2015.230

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  6 in total

Review 1.  Methicillin-Resistant Staphylococcus aureus Control in the 21st Century: Laboratory Involvement Affecting Disease Impact and Economic Benefit from Large Population Studies.

Authors:  Lance R Peterson; Donna M Schora
Journal:  J Clin Microbiol       Date:  2016-06-15       Impact factor: 5.948

Review 2.  Fecal Carriage of Staphylococcus aureus in the Hospital and Community Setting: A Systematic Review.

Authors:  Shantelle Claassen-Weitz; Adebayo O Shittu; Michelle R Ngwarai; Lehana Thabane; Mark P Nicol; Mamadou Kaba
Journal:  Front Microbiol       Date:  2016-05-10       Impact factor: 5.640

3.  The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis.

Authors:  Helen J Stacey; Caitlin S Clements; Susan C Welburn; Joshua D Jones
Journal:  Acta Diabetol       Date:  2019-04-06       Impact factor: 4.280

4.  Modelling pathogen spread in a healthcare network: Indirect patient movements.

Authors:  Monika J Piotrowska; Konrad Sakowski; André Karch; Hannan Tahir; Johannes Horn; Mirjam E Kretzschmar; Rafael T Mikolajczyk
Journal:  PLoS Comput Biol       Date:  2020-11-30       Impact factor: 4.475

5.  Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Virginia R Roth; Tara Longpre; Doug Coyle; Kathryn N Suh; Monica Taljaard; Katherine A Muldoon; Karamchand Ramotar; Alan Forster
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

Review 6.  The Prevalence, Risk, and Management of Methicillin-Resistant Staphylococcus aureus Infection in Diverse Populations across Canada: A Systematic Review.

Authors:  Elena Mitevska; Britney Wong; Bas G J Surewaard; Craig N Jenne
Journal:  Pathogens       Date:  2021-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.